Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Neoplasm Metastasis 1Hodgkin Disease 1Colorectal Neoplasms 1

Interventions

enzalutamide 28Magnetic Resonance Spectroscopy 28Specimen Handling 21apalutamide 18Androgen Antagonists 16Abiraterone Acetate 15Prednisone 14Radiosurgery 13abiraterone 12Docetaxel 12Radiotherapy 11Biopsy 10darolutamide 9Nivolumab 8Radiation 7Pluvicto 72-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 7niraparib 6luprolide acetate gel depot 6cabazitaxel 6Surveys and Questionnaires 6gallium 68 PSMA-11 5bicalutamide 5Radiotherapy, Intensity-Modulated 5Lutetium-177 5Leuprolide 5Gonadotropin-Releasing Hormone 5radium Ra 223 dichloride 4pembrolizumab 4olaparib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Immunohistochemistry × 30 days × Clear all
NCT07597369 2026-05-19

Clinically Actionable Tumor-Associated Antigens in Prostate Cancer

Peking University First Hospital

Active not recruiting
1,600 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡